Anika Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Anika Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Anika Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 14.7M shares, a 0.39% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 14.7M +57K +0.39% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 14.8M +182K +1.24% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 14.8M +80K +0.54% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 14.7M +35K +0.24% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 14.6M +30K +0.21% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 14.7M +59K +0.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 14.7M +223K +1.54% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 14.6M +184K +1.27% Dec 31, 2022 10-K 2024-03-15
Q3 2022 14.6M +171K +1.19% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 14.6M +180K +1.25% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 14.5M +152K +1.06% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 14.4M +112K +0.78% Dec 31, 2021 10-K 2023-03-16
Q3 2021 14.4M +228K +1.61% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 14.4M +214K +1.51% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 14.4M +168K +1.18% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 14.3M +21K +0.15% Dec 31, 2020 10-K 2022-03-11
Q3 2020 14.2M -61K -0.43% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 14.2M +419K +3.04% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 14.2M -16K -0.11% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 14.3M +98K +0.69% Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 14.3M +58K +0.41% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 13.8M -799K -5.48% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 14.2M -531K -3.6% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 14.2M -478K -3.25% Dec 31, 2018 10-K 2020-03-06
Q3 2018 14.2M -451K -3.08% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 14.6M -74K -0.51% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 14.7M +90K +0.61% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 14.7M +61K +0.42% Dec 31, 2017 10-K 2019-02-27
Q3 2017 14.7M +39K +0.27% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 14.7M -120K -0.81% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 14.7M -113K -0.77% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 14.6M -410K -2.73% Dec 31, 2016 10-K 2018-02-27
Q3 2016 14.6M -389K -2.59% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 14.8M -226K -1.51% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 14.8M -235K -1.57% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 15M +185K +1.25% Dec 31, 2015 10-K 2017-02-24
Q3 2015 15M +211K +1.43% Sep 30, 2015 10-Q 2015-11-03
Q2 2015 15M +206K +1.39% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 15M +383K +2.62% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 14.9M +562K +3.94% Dec 31, 2014 10-K 2016-03-10
Q3 2014 14.8M +534K +3.75% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 14.8M +781K +5.57% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 14.6M +614K +4.38% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 14.3M +423K +3.05% Dec 31, 2013 10-K 2015-03-13
Q3 2013 14.3M +461K +3.34% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 14M +251K +1.83% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 14M +243K +1.77% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 13.9M +235K +1.73% Dec 31, 2012 10-K 2014-03-13
Q3 2012 13.8M +183K +1.34% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 13.8M +144K +1.06% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 13.8M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 13.6M +148K +1.1% Dec 31, 2011 10-K 2013-03-14
Q3 2011 13.6M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 13.6M Jun 30, 2011 10-Q/A 2011-08-10
Q4 2010 13.5M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.